This Award Notice opportunity from Department Of Defense was posted on August 25, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
HYDROCORTISONE CREA
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
Defense Logistics Agency award SPE2DP22F1398 was issued to DMS Pharmaceutical Group Inc under delivery order SPE2DX15D9383 for the procurement of Hydrocortisone Crea. The contract was managed by the DLA Troop Support Medical Supply Chain FSB as a commercial items order. Despite the award notice, modification P00001 resulted in a total cancellation of the contract at no cost or liability to either the government or the contractor. This action cancelled CLIN 0001, reducing the contract value from 61.20 dollars to zero. The termination was executed for the government's convenience due to vendor non-performance and aged, undelivered delivery orders.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
